Immune checkpoint inhibitor-induced multi-organ immune damage complicated by severe pneumonia: case report
Immune checkpoint inhibitor (ICI) have substantially extended survival in patients with extensive-stage small-cell lung cancer (ES-SCLC), yet they also carry the risk of life-threatening immune-related adverse events (irAEs). Clinical experience in man…